John Connor Named Chief Business Development Officer for MCUSA Consulting
BELLINGHAM, Wash.–(BUSINESS WIRE)–MCUSA Consulting announced today the appointment of John Connor as chief business development officer. In his new role,... Read more.
Pi Health to Collaborate with GSK to Enhance Clinical Research Services
Pi Health to use its proprietary technology platform to provide end-to-end global clinical research services in a Phase 2 oncology clinical trial with GSK Physician-led... Read more.
FORTÉ Expands Internationally With Acquisition of Informationsteknik in Sweden and Denmark
MINNEAPOLIS–(BUSINESS WIRE)–FORTÉ, formerly AVI Systems, today announced it has acquired Informationsteknik Scandinavia AB, headquartered in Stockholm,... Read more.
flyExclusive Added to the Russell U.S. Indexes
KINSTON, N.C.–(BUSINESS WIRE)–flyExclusive, Inc. (NYSEAMERICAN: FLYX) (“flyExclusive” or the “Company”), a leading provider of premium private... Read more.
NRG Energy, Inc. Announces Offerings of Senior Secured Notes and Senior Unsecured Notes
HOUSTON–(BUSINESS WIRE)–NRG Energy, Inc. (NYSE:NRG) announced today the commencement of concurrent offerings of (1) senior secured first lien notes (the... Read more.
The Real Brokerage Surpasses 30,000-Agent Milestone
Technology-powered end-to-end platform continues to outpace the industry in agent attraction MIAMI–(BUSINESS WIRE)–$REAX #therealbrokerage–The... Read more.
Innovex Completes Sale of Dril-Quip Eldridge Facility
HOUSTON–(BUSINESS WIRE)–#innovex–Innovex International, Inc. (NYSE: INVX) (the “Company,” “Innovex” or “we”) announced that it has... Read more.
Pay Governance’s Tara Tays Named 2025 NACD Directorship 100™ Honoree
NEW YORK–(BUSINESS WIRE)–#PayGovernance–Tara Tays of Pay Governance, a top executive compensation consulting firm, has been named a 2025 NACD Directorship... Read more.
Cure Rare Disease Secures FDA Orphan Drug Designation for Investigational Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type R9 (LGMD2i/R9)
Designation supports development of CRD-003, an investigational therapy targeting the root cause of Limb-Girdle Muscular Dystrophy Type R9 WOODBRIDGE, Conn.–(BUSINESS... Read more.
Mirion To Acquire Paragon Energy Solutions, one of the Leading Providers of Highly Engineered Solutions for Large-scale Nuclear Power Plants and Small Modular Reactors (SMRs) in the United States
Broadens Mirion’s portfolio of offerings for nuclear power customers, including SMRs Attractive purchase price of $585 million in cash Accretive to diluted EPS... Read more.